open access

Vol 61, No 6 (2010)
Case report
Published online: 2010-11-15
Submitted: 2013-02-15
Get Citation

Abnormal dexamethasone suppression tests in a rifampicin-treated patient with suspected Cushing’s syndrome

Harris Ngow Abdullah, Wan Khairina Won Mohd Nowalid
Endokrynologia Polska 2010;61(6):706-709.

open access

Vol 61, No 6 (2010)
Case report
Published online: 2010-11-15
Submitted: 2013-02-15

Abstract

The dexamethasone suppression test is a useful endocrinological test to diagnose Cushing’s syndrome. However, its interpretation may be influenced by many factors such as stress, alcohol, failure to ingest the dexamethasone, altered metabolism, drug interaction and obesity. This report illustrates such an instance, whereby the result of the test was erratic due to the anti-tuberculous drug rifampicin. Rifampicin has been found to profoundly attenuate the biological effects of dexamethasone, probably by enhancing its metabolism in the liver. The exact mechanism of the drug interaction remains elusive, though induction of hepatic CYP3A4 enzyme complex is a possible mechanism. In a patient treated with rifampicin, the results of dexamethasone suppression tests thus have no diagnostic value and can be very misleading.
(Pol J Endocrinol 2010; 61 (6): 706-709)

Abstract

The dexamethasone suppression test is a useful endocrinological test to diagnose Cushing’s syndrome. However, its interpretation may be influenced by many factors such as stress, alcohol, failure to ingest the dexamethasone, altered metabolism, drug interaction and obesity. This report illustrates such an instance, whereby the result of the test was erratic due to the anti-tuberculous drug rifampicin. Rifampicin has been found to profoundly attenuate the biological effects of dexamethasone, probably by enhancing its metabolism in the liver. The exact mechanism of the drug interaction remains elusive, though induction of hepatic CYP3A4 enzyme complex is a possible mechanism. In a patient treated with rifampicin, the results of dexamethasone suppression tests thus have no diagnostic value and can be very misleading.
(Pol J Endocrinol 2010; 61 (6): 706-709)
Get Citation

Keywords

dexamethasone suppression test; rifampicin; Cushing’s syndrome; biological effect; drug interaction

About this article
Title

Abnormal dexamethasone suppression tests in a rifampicin-treated patient with suspected Cushing’s syndrome

Journal

Endokrynologia Polska

Issue

Vol 61, No 6 (2010)

Pages

706-709

Published online

2010-11-15

Bibliographic record

Endokrynologia Polska 2010;61(6):706-709.

Keywords

dexamethasone suppression test
rifampicin
Cushing’s syndrome
biological effect
drug interaction

Authors

Harris Ngow Abdullah
Wan Khairina Won Mohd Nowalid

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl